论文部分内容阅读
据世界卫生组织国际癌症研究署(International Agency for Research on Cancer,IARC)统计,宫颈癌是女性生殖系统最常见的恶性肿瘤之一,全球宫颈癌发病率在女性恶性肿瘤中居第二位,占所有女性恶性肿瘤的13%。全球每年新发宫颈癌中59%发生在亚洲~[1]。有调查统计,我国的宫颈癌发病率为12.96/10万,死亡率为4.32/10万,呈明显增长趋势[2]。目前,宫颈癌的传统治疗方式主要有手术治疗、放疗、化疗等,但这些治疗方法均存在着相对的不足。
According to the International Agency for Research on Cancer (IARC), cervical cancer is one of the most common malignant tumors of the female reproductive system. The incidence of cervical cancer in the world ranks second among all female malignancies, 13% of female malignant tumors. Fifty-nine percent of new cervical cancers worldwide each year occur in Asia ~ [1]. A survey shows that the incidence of cervical cancer in China was 12.96 / 100,000, the mortality rate was 4.32 / 100,000, showing a clear trend of growth [2]. At present, the traditional treatment of cervical cancer are mainly surgical treatment, radiotherapy, chemotherapy, etc., but these treatments are there are relative deficiencies.